Anticancer activity of 2-(2-(5-nitro-2-furyl)vinyl)-8-(beta-(N,N-diethylamino)ethoxy)quinoline.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D008113:Liver Neoplasms; D008297:Male; D051379:Mice; D009581:Nitrofurans / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy
D000970:Antineoplastic Agents; D009581:Nitrofurans; D011804:Quinolines